November 2020 – Headquartered in Cambridge, MA Seres Therapeutics is a late-clinical stage biotechnology company working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome.

October 2020 — Headquartered in South San Francisco, CA, Atreca focuses on the immune response of patients in therapeutic areas where such responses are the key phenomenon driving clinical outcomes, enabling us to discover and develop novel immunotherapies, including those in our lead programs in Oncology.

October 2020 — With offices in Waltham, MA, Adagio's mission is to provide an effective long-term solution for the global Coronavirus challenge.

September 2020 — Located in Austin, TX, Molecular Templates is focused on the discovery, development and commercialization of next generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancer.

August 2020 — With offices in Cambridge, MA, Celsius' mission is to develop life-saving medicines and discover critical biomarkers for patient care by better understanding the cellular ecosystem of diseases through Single Cell Genomics and Machine Learning.

February 2020 — With offices in Cambridge, MA, Beam Therapeutics is a biotechnology company committed to creating a new class of precision genetic medicines based on proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.

January 2020 — With US offices in San Diego and South San Francisco, Shouti Pharmaceuticals will be using R&D Logic's R&D Time to manage and prioritize portfolio resources.